logo
バナー バナー

ニュースの細部

ホーム > ニュース >

企業ニュース The method for preparing Sodium stearyl fumarate has been granted a patent by the United States.

イベント
送信
Ms. Haileeping
86-0554-2796186
今接触

The method for preparing Sodium stearyl fumarate has been granted a patent by the United States.

2026-01-27

Recently, the company independently developed "A pharmaceutical excipient with a uniform sheet structure - Sodium stearyl fumarate and its preparation method" has been granted a US patent (US12,508,314B2).

Sodium stearyl fumarate is a widely used pharmaceutical excipient, mainly serving as a lubricant for tablets and capsules. This excipient has good compatibility and can be applied to the majority of active pharmaceutical ingredients (APIs); it has little impact on the disintegration time, hardness, and drug dissolution behavior of tablets, and is particularly suitable for the formulation of poorly soluble drugs.

The company is committed to strengthening intellectual property protection, promoting technological innovation and product upgrading, adhering to the concept of innovation-driven development, and continuously enhancing its core competitiveness to provide customers with higher-quality products and services.

バナー
ニュースの細部
ホーム > ニュース >

企業ニュース-The method for preparing Sodium stearyl fumarate has been granted a patent by the United States.

The method for preparing Sodium stearyl fumarate has been granted a patent by the United States.

2026-01-27

Recently, the company independently developed "A pharmaceutical excipient with a uniform sheet structure - Sodium stearyl fumarate and its preparation method" has been granted a US patent (US12,508,314B2).

Sodium stearyl fumarate is a widely used pharmaceutical excipient, mainly serving as a lubricant for tablets and capsules. This excipient has good compatibility and can be applied to the majority of active pharmaceutical ingredients (APIs); it has little impact on the disintegration time, hardness, and drug dissolution behavior of tablets, and is particularly suitable for the formulation of poorly soluble drugs.

The company is committed to strengthening intellectual property protection, promoting technological innovation and product upgrading, adhering to the concept of innovation-driven development, and continuously enhancing its core competitiveness to provide customers with higher-quality products and services.